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Abstract 
7-Nitro indazole (25-100 mg/kg i.p.), an inhibitor of neuronal nitric oxide (NO) synthase, attenuated the severity of 
pilocarpine (300 mg/kg i.p.)-induced seizures in mice. This indicates that the decreased neuroexcitability of the central nervous 
system (CNS) following administration f 7-nitro indazole may be due to inhibition of neuronal NO synthase, implying that NO 
acts as an excitatory and proconvulsant factor in the CNS. 
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1. Introduction 
As a retrograde messenger, nitric oxide (NO) in- 
duces presynaptically the release of several neurotrans- 
mitters, including the excitatory amino acid, L-gluta- 
mate (Montague et al., 1994). This indicates that NO 
deranges the neurotransmitter balance in the central 
nervous ystem (CNS) and affects neuronal excitability. 
Therefore, the role of NO in epilepsy has been investi- 
gated by several authors, who used various NO syn- 
thase inhibitors. However, these experiments have 
yielded conflicting results. 
The NO synthase inhibitors, L-NAME (L-N C ni- 
troarginine methyl ester) and L-NMMA (L-NG-mono - 
methylarginine) attenuated pentylenetetrazol-induced 
seizures in rats (Osonoe et al., 1994) and kainate-in- 
duced seizures in mice (Przegalinski et al., 1994). These 
results suggested that NO is an endogenous proconvul- 
sant agent. In contrast, administration of L-NAME 
increased convulsions induced by NMDA (N-methyl- 
D-aspartate) in mice (Buisson et al., 1993). Another 
NO synthase inhibitor, L-NOARG (L-N G nitroargi- 
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nine), potentiated seizures induced in rats by various 
convulsant compounds, such as quinolinate (Haberny 
et al., 1992), kainic acid (Rondouin et al., 1993) and 
bicuculline (Wang et al., 1994). These data indicated 
that NO is an endogenous anticonvulsant substance. 
All NO synthase inhibitors used in these studies are 
alkyl esters of arginine and affect both neuronal NO 
synthase and endothelial NO synthase. These alkyl 
esters induce hypertension, caused by inhibition of 
endothelial NO synthase. It is known that an acute 
increase in blood pressure may cause arousal from 
sleep, indicating that hypertensive agents may affect 
excitability of central neurons (Fevell and Johnson, 
1994). Another relevant fact is that L-NAME and 
other alkyl esters of arginine are muscarinic receptor 
antagonists (Buxton et al., 1993). This means that, in 
addition to inhibiting NO synthesis, they may affect 
neuronal excitability by derangement of other neuro- 
transmitters as well. 
In order to avoid the effect of arginine-derived NO 
synthase inhibitors on blood pressure and muscarinic 
receptors, we used 7-nitro indazole, an inhibitor of 
neuronal NO synthase, which does not affect endothe- 
lial NO synthase (in vivo) and blood pressure (Moore 
et al., 1993). We examined the effect of 7-nitro inda- 
zole on pilocarpine-induced seizures in mice since, in 
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cholinergic models of epilepsy, L-NAME exerted both 
stimulation (Starr and Starr, 1993) and inhibition of 
seizure activity (Bagetta et al., 1992). 
2. Materials and methods 
The experiments were performed on 100 male Swiss 
mice (29-47 g). One group of animals (n = 20) re- 
ceived vehicle (arachis oil) intraperitoneally (i.p.), while 
the other three groups (each 20 animals) were treated 
with one of three doses of 7-nitro indazole (25, 50 and 
100 mg/kg i.p.). An additional group of animals (n = 
20) was given L-arginine (300 mg/kg i.p.), injected 60 
min prior to pilocarpine. Seizures were induced with 
pilocarpine (300 mg/kg i.p.), administered 30min after 
injection of vehicle or 7-nitro indazole. A maximum 
inhibition of neuronal NO synthase in mice occurred 
18-30 min following administration f 7-nitro indazole 
(50 mg/kg i.p.; Moore et al., 1993), while pilocarpine- 
induced seizure started 10-15 min after injection of 
pilocarpine (300 mg/kg i.p.; Turski et al., 1984). The 
schedules of injections of drugs guaranteed an occur- 
rence of pilocarpine seizure during the most pro- 
nounced decrease of brain NO synthase activity. In 
order to minimize peripheral cholinergic effects, 
scopolamine (1 mg/kg) was injected subcutaneously 
(s.c.), 30 min prior to administration of pilocarpine 
(Turski et al., 1984). The seizures were evaluated by 
observation of the latency, behavioral pattern of 
seizures (clonic/tonic) and mortality. The animals were 
observed for a period of 90 min following pilocarpine 
injection. 
7-Nitro indazole (Lancaster, UK) was suspended in
arachis oil by sonication and was used in a dose range 
shown to inhibit neuronal NO synthase (Moore et al., 
1993). Pilocarpine hydrochloride, scopolamine methyl- 
nitrate (Sigma) and L-arginine hydrochloride (Sigma) 
were freshly dissolved in distilled water. 
The comparisons were done with binomial test. Sta- 
tistical significance was accepted at a probability (P) 
value of 0.05 or less. 
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Fig. 1. Frequency of pilocarpine (300 mg/kg i.p.)-induced 
tonic/clonic seizures and lethality in mice (n = 80, divided in 4 equal 
groups), pretreated with vehicle (arachis oil i.p.) or 7-nitro indazole 
(i.p.). Pilocarpine was administered 30 min following vehicle or 
7-nitro indazole. The data are expressed as percentages of the effect 
of pilocarpine in vehicle-treated animals (n = 20). Significance at 
P < 0.05 level (binomial test) with respect o vehicle-treated group. 
Note the dose-dependent and bell-shaped ecrease in seizure fre- 
quency and lethality following administration f 7-nitro indazole. 
group was 13 min. The percentages of pilocarpine-in- 
duced convulsions and lethality in the control group 
were 90% and 70%, respectively. Administration of 
vehicle had no overt effect on the behaviour of the 
animals. 
Administration of 7-nitro indazole (25, 50 and 100 
mg/kg i.p., to 60 animals divided into three equal 
groups for each dose, 30 min prior to pilocarpine), 
decreased significantly the frequency of seizures and 
lethality in pilocarpine (300 mg/kg i.p.)-treated mice 
(Fig. 1). The plot of the decrease in seizure frequency 
and lethality was bell-shaped. The latency of seizures 
was not significantly affected by 7-nitro indazole. The 
mean value of seizure latency in animals treated with 
7-nitro indazole (25, 50 and 100 mg/kg) was in the 
range of 12-16 min, while in the control group it was 
13 min. L-Arginine (300 mg/kg i.p., 30 min prior to 
7-nitro indazole and 60 min prior to pilocarpine, n -- 20) 
did not affect he anticonvulsant effect of 7-nitro inda- 
zole (50 mg/kg i.p.). 
4. Discussion 
3. Results 
Administration of pilocarpine (300 mg/kg i.p.) to 
mice (n = 20), 30 min after the vehicle (arachis oil i.p.) 
induced a sequence of behavioral alterations consisting 
of initial akinesia, grooming, body tremor and saliva- 
tion. These symptoms appeared within 5-10 min fol- 
lowing pilocarpine injection. This preconvulsant be- 
haviour built up to tonic/clonic seizures. In some 
animals paroxysmal ctivity resulted in status epilepti- 
cus, which was generally lethal to mice. The mean 
latency of the first tonic-clonic seizure in the control 
This study showed that pilocarpine-induced seizures 
and lethality in mice can be prevented by 7-nitro inda- 
zole. However, the anticonvulsant effect of 7-nitro in- 
dazole and the decrease in lethality were less pro- 
nounced after a high dose of this drug. This might 
indicate that higher doses of 7-nitro indazole (above 50 
mg/kg i.p.) possess ome additional non-specific effect, 
unrelated to brain NO synthase inhibition. The anti- 
convulsant effect of 7-nitro indazole contrasts with the 
effect of the NO synthase inhibitor, L-NAME, which 
was found to be proconvulsant when injected in con- 
junction with a subconvulsant dose of pilocarpine (100 
mg/kg i.p.) and which failed to protect mice against 
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seizures induced by high dose of pilocarpine (400 
mg/kg i.p., Starr and Starr, 1993). A high dose of 
pilocarpine (400 mg/kg i.p.) is generally considered as 
lethal to mice (Turski et al., 1984) and this may prevent 
the detection of the corresponding effect of L-NAME. 
The mechanism of the proconvulsant effect of L- 
NAME in the presence of a subconvulsant dose of 
pilocarpine (100 mg/kg i.p.) is not clear. Although we 
have no explanation of this effect of L-NAME, it might 
be possible that the discrepancies between results of 
two studies, with the same animal model of epilepsy 
are due to differences between actions of L-NAME 
and 7-nitro indazole, unrelated to brain NO synthase. 
Our results are, however, consistent with the anticon- 
vulsant effect of L-NAME in another cholinergic model 
of seizure, using as convulsant agent an acetyl- 
cholinesterase inhibitor, tacrine (1,2,3,4-tetrahydro-9- 
amonoacrodine; Bagetta et al., 1992). The present re- 
sults are also consistent with those of a recent study 
showing that 7-nitro indazole (40 mg/kg i.p.) attenu- 
ates kainate-elicited convulsions in rats (Miilsch et al., 
1994). All these data support he idea of a proconvul- 
sant role of central NO. 
However, in our study this idea was not confirmed 
when the NO precursor, L-arginine, was co-adminis- 
tered with 7-nitro indazole. Although, L-arginine in- 
jected in the prepiriform cortex potentiates excitatory 
amino acid-induced seizures in rats (De Sarro et al., 
1993) and mice (Przegalinski et al., 1994), no overt 
effect was observed on the behaviour of mice chal- 
lenged with a threshold convulsant dose of pilocarpine 
(100 mg/kg i.p.; Starr and Starr, 1993). Furthermore, 
concomitant administration of L-arginine (500 mg/kg 
i.p.) prevented the conxaJlsant effect of 5 mg/kg L- 
NAME, but was ineffective against 25 mg/kg L-NAME 
(Starr and Starr, 1993). Evidently, the species (phar- 
macokinetic factors), doses and brain concentrations of 
L-arginine, and some other factors related to the NO 
synthase inhibitor (possible complex interactions of 
7-nitro indazole with other parts of the enzyme, for 
example with tetrahydrobiopterin) may significantly de- 
termine the effect of L-arginine on seizure phenomena 
affected by NO synthase inhibitors. In this context, a 
failure of L-arginine to antagonize the anticonvulsant 
effect of 7-nitro indazole does not confirm, but does 
not exclude, apossibility that observed effects of 7-nitro 
indazole are mediated by inhibition of brain NO syn- 
thase. Although it is most likely that effects of moder- 
ate doses of 7-nitro indazole (25-50 mg/kg) are medi- 
ated by inhibition of brain NO synthase, it seems that 
the non-specific effects (unrelated to brain NO syn- 
thase inhibition) of high doses of 7-nitro indazole 
(above 50 mg/kg), should not be ruled out. 
In conclusion, this study showed that 7-nitro inda- 
zole, a selective inhibitor of neuronal NO synthase, 
decreases the frequency .and lethality of pilocarpine-in- 
duced seizures in mice. This implicates that NO acts as 
a central neurotransmitter with proconvulsant proper- 
ties. Although the pharmacology of 7-nitro indazole is 
not yet completely clarified, particularly the effects of 
high doses of 7-nitro indazole, we are suggesting that 
7-nitro indazole, devoid of a vasopressor effect is 
presently an appropriate tool to study the role of NO 
in seizure and other central phenomena. 
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